In the last trading session, 1.23 million Arcus Biosciences Inc (NYSE:RCUS) shares changed hands as the company’s beta touched 0.80. With the company’s per share price at $8.71 changed hands at $0.15 or 1.75% during last session, the market valuation stood at $922.26M. RCUS’s last price was a discount, traded about -117.91% off its 52-week high of $18.98. The share price had its 52-week low at $6.50, which suggests the last value was 25.37% up since then.
Analysts gave the Arcus Biosciences Inc (RCUS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.38. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended RCUS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Arcus Biosciences Inc (NYSE:RCUS) trade information
Instantly RCUS was in green as seen at the end of in last trading. With action -1.02%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -41.50%, with the 5-day performance at -1.02% in the red. However, in the 30-day time frame, Arcus Biosciences Inc (NYSE:RCUS) is 10.53% up.
The consensus price target for the stock as assigned by Wall Street analysts is 26, meaning bulls need an upside of 66.5% from its current market value. According to analyst projections, RCUS’s forecast low is 26 with 26 as the target high. To hit the forecast high, the stock’s price needs a -198.51% plunge from its current level, while the stock would need to soar -198.51% for it to hit the projected low.
Arcus Biosciences Inc (RCUS) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -10.20%. The 2025 estimates are for Arcus Biosciences Inc earnings to decrease by -44.65%, but the outlook for the next 5-year period is at -6.52% per year.
Arcus Biosciences Inc (NYSE:RCUS)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 6.099% or 5.26 million shares worth $80.07 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. With 4.24 shares estimated at $36.91 million under it, the former controlled 4.00% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 1.49% of the shares, roughly 1.58 shares worth around $13.79 million.
